US Patent Issued to VIROMETIX, UNIVERSITAT ZURICH on Feb. 17 for "Cyclic peptides for protection against respiratory syncytial virus" (Swiss Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,839, issued on Feb. 17, was assigned to VIROMETIX AG (Schlieren, Switzerland) and UNIVERSITAT ZURICH (Zurich, Switzerland).

"Cyclic peptides for protection against respiratory syncytial virus" was invented by Arin Ghasparian (Zurich), Armando Zuniga (Zurich), Aniebrys Marrero Nodarse (Zurich), Oliver Rassek (Adliswil, Switzerland), John A. Robinson (Kemptthal, Switzerland) and Kerstin Mohle (Wettswil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cyclic peptide, a conjugate comprising said cyclic peptide and a lipopeptide building block, a bundle of said conjugates, a synthetic virus-like particle comp...